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MAAZI And AKBARI CD1a, CD123 in humans. 15 Since ILC2s have been identified as IL -33 or IL-25 responsive innate lymphoid cells, all murine innate lymphoid cells, lineage-negative CD45 + cells, that express the IL-33 receptor, ST2 or IL-25 (IL-17RB) receptor would be considered as ILC2s. 5, 6, 13 However, several other cell surface markers have been described for further distinction of both murine and human ILC2s among all innate lymphoid cell population, including Inducible T cell Costimulator (ICOS), Killer cell lectin-like receptor subfamily G member 1 (KLRG-1)
and cytokine receptors IL-7 receptor-α, and IL-2 receptor-α. 16 Murine but not human ILC2s also express CD90 (Thy1). 16, 17 Human ILC2s express CD161, CCR6 and Prostaglandin D2 receptor 2 (CRTH2). 17, 18 ST2 is not detectable in freshly isolated human ILC2s, however, these cells respond to IL-33 after in vitro stimulation for at least 12 hours.
18
ILC2s have been detected in the lungs, gastrointestinal tract, adipose tissue, skin, oral mucosa, secondary lymphoid organs, and blood of humans and mice. 15, 17, 19 ILC2s constitute a significant proportion of murine pulmonary innate lymphoid cells whereas, in humans ILC2s
are less than 3% of total innate lymphoid cells in the lungs. 15, 17, 19 In the skin of humans and mice, ILC2s constitute the majority of innate lymphoid cells. 20 
| ACTIVATION OF ILC2S AND THEIR CYTOKINE REPERTOIRE

| Cytokine repertoire of ILC2s
Although ILC2s were initially identified as IL-5 and IL-13 producing cells, 5, 6, 21 they can produce several other cytokines including, IL-9, and
IL-4. Recent transcriptional analysis of ILC2s and the evidence from the
Immunological Genome Consortium show that murine ILC2s express genes of IL-2, Granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-6. 22, 23 Production of IL-4, IL-5, IL-9, IL-13, GM-CSF, and IL-6 by human ILC2s has been also shown at the protein level. 17 IL-10 production by a subset of CD127 + Sca-1 + CD25 + innate lymphoid cells has been reported in a murine model of contact hypersensitivity. 24 Whether these IL-10 producing cells are a subset of ILC2s or a distinct subset of innate lymphoid cells remains to be elucidated.
| Activation of ILC2s by cytokines
ILC2s are terminally differentiated effector lymphocytes, armed with multiple mechanisms to sense a variety of danger signals which enables them to rapidly evoke an immune response by producing large quantities of cytokines. Unlike conventional lymphocytes, ILC2s lack antigen specific receptors and are activated through danger signals.
Tissue damage and stress upon pathologic conditions lead to the production of danger signals including cytokines such as IL-33, IL-25, thymic stromal lymphopoietin (TSLP), prostaglandins, and leukotrienes, all of which could be sensed by murine and human ILC2s. In addition, human ILC2s are activated by IL-1β and IL-18. 17, 18 Activated human ILC2s by IL-1β produce IL-5 and IL-13. 18 Although, IL-33 and IL-25 can both activate ILC2s to produce cytokines and proliferate, IL-33 seems to be more potent in activating ILC2s than IL-25. 25 To date, subsets of ILC2s that distinctly differ in phenotype and function have not been identified and it remains to be identified whether cytokine responsiveness can determine distinct subsets of ILC2s. There is evidence suggesting that IL-25-responsive
ILC2s can develop to IL-33-reponsive ILC2 in vivo and in vitro. 26 However, further studies are required to clearly determine whether IL-25-responsive ILC2s are different from the previously described multipotent progenitor type 2 cells. 27 IL-9 is produced by several immune cells including Th9 and mast cells and contributes to worm expulsion and the asthma pathogenesis. 28, 29 There is evidence indicating that IL-9 plays a major role in the survival of ILC2s and their production of IL-5 and IL-13. 30, 31 Interestingly, ILC2s produce significant amount of IL-9 and has been shown that autocrine IL-9 is an important component in the homeostasis and optimal function of ILC2s. 32 Depending on the environmental factors and pathologic conditions, however, different factors seem to stimulate the production of IL-9 by either ILC2s or other cells such as mast cells. 32, 33 Several pathways have been described to stimulate IL-9 production by ILC2s.
IL-2 is the first cytokine that has been reported to be required for IL-9
production by ILC2s. 30 It has been shown that IL-2 plays a major role in ILC2-mediated induction of type 2 lung inflammatory conditions in mice by acting as a survival factor and as a cofactor for their cytokine production. 34 IL-2 is also an essential cytokine for ex vivo stimulation and culture of ILC2s. 30, 35 So, IL-2 stimulates the production of IL-9 by ILC2s which is in turn required for the proliferation and cytokine production by these cells. It remains to be investigated whether IL-2-stimulation is dispensable in the presence of exogenous IL-9.
A different line of research suggests that IL-4 can enhance production of IL-9 by ILC2s. 36 This pathway seems to be an important factor in response to papain and allergens with protease activity. 36 IL-9 is such an important cytokine for proliferation and activation of ILC2s that the lack of T-bet, an ILC1 associated transcription factor, caused exaggerated ILC2s response by unleashing the production of IL-9.
37
There is evidence suggesting that TSLP in synergy with IL-33 plays a role in IL-9 production by ILC2s. 32 This pathway seems to be critical in efficient ILC2-mediated anti-helminth infection. Apart from the effects of IL-9 production, TSLP stimulation has been found to activate
ILC2s independent of IL-33 or IL-25 in the skin. 38 Recently, two lines of evidence suggested a role for TL1A, a member of tumor necrosis factor superfamily, in activating ILC2s and developing type 2 pathology independent of IL-33 or IL-25. 39, 40 Human ILC2s also express IL-18 receptor and respond to IL-18 stimulation in a fashion similar to IL-33 and produce IL-4, IL-5, IL-9, IL-13, GM-CSF, and IL-6. 
| Activation of ILC2s by eicosanoids
Under inflammatory conditions, a family of lipid mediators called 'eicosanoids' are generated from arachidonic acid which itself is a product of phospholipids. 41 The four sub-families of eicosanoids including prostaglandins, leukotrienes, lipoxins, and prostacyclin play important roles in development and resolution of inflammation. 41 Leukotrienes are generated by lipoxygenase enzymes whereas generation of prostaglandins and prostacyclin are mediated by cyclooxygenase enzymes. 41 Given the therapeutic potentials of eicosanoids, their effects on ILC2s, particularly in asthma pathogenesis have been well studied. As discussed below, prostaglandins, leukotrienes, lipoxins, and prostacyclin have opposing effects on ILC2s.
Prostaglandin D2 (PGD2) has been shown to activate human ILC2s   to produce IL-4, IL-5, and IL-13.  42 PGD2 also increases the expression of IL-33 and IL-25 receptors and synergizes the effects of IL-33 and IL-25 in cytokine production by human ILC2s. 42 One important effect of PGD2 on ILC2s is inducing chemotaxis. It has been shown that the frequency of CRTH2 expressing ILC2s are lower in the lungs than in the peripheral blood of non-asthmatic humans and that PGD2 is a strong chemoattractant for human ILC2s. [42] [43] [44] Further studies are required to determine whether the frequency of CRTH2 expressing
ILC2s are higher in the lungs of asthmatic patients than non-asthmatic individuals. Unlike PGD2, prostaglandin I2 (PGI2), and lipoxins A4 have regulatory effects of ILC2s which are discussed below.
Cysteinyl leukotrienes (cysLT) are inflammatory mediators generated by eosinophils, basophils, mast cells, macrophages, and myeloid dendritic cells (DCs) and play important roles in the pathogenesis of asthma and allergy through incompletely understood mechanisms. [45] [46] [47] Activation of ILC2s may be an important mechanism of contribution of cysLTs to asthma pathogenesis. Human and murine
ILC2s express cysLT receptor-1 and can be activated by cysLTs C4, D4, E4, or cysLT-R1 agonists. 48, 49 Recently it was shown that peripheral ILC2s from patients with atopic dermatitis express higher level of cysLT receptor than those of non-atopic individuals and that cysLTs, in particular, LTE4 augment the activation of human ILC2s by IL-25, IL-33, TSLP or PGD2. 49 The same study showed that the effects of cysLTs were inhibited by antagonist to cysLT receptor.
| REGULATION OF ILC2S
| Regulation of ILC2s by co-stimulatory molecule
Like other components of immune system, ILC2s homeostasis and function need to be regulated to prevent deleterious immune responses. The mechanisms of regulation of ILC2s have been studied at different levels of extrinsic and intrinsic molecular pathways as well as the regulatory effects of other cells on ILC2s. One of the most described co-stimulatory molecules that plays an important role in the homeostasis and regulation of function of ILC2s is ICOS. 15, [50] [51] [52] [53] ILC2s express ICOS and we were the first to discover that ILC2s also express ICOS-L. 15, 50, 51 We showed that the genetic ablation of ICOS increases the apoptosis rate and impairs the cytokine production by ILC2s. 15 We further showed that genetic ablation of ICOS or blocking ICOS/ ICOS-L interaction leads to reduced ILC2-mediated airway hyperreactivity and lung inflammation. Adoptively transferred ICOS-deficient
ILC2s resulted in an attenuated airway hyperreactivity and lung inflammation in alymphoid hosts compare to wild type ILC2s. 15, 50, 51 We introduced the first humanized murine model for ILC2-mediated asthma which provides a unique platform for studying the role of human ILC2s in asthma pathogenesis and for identifying novel therapeutic approaches for asthma. 15 Mechanistically, we showed that in PGI2 and Lipoxin A4 are eicosanoids that suppress ILC2s. Addition of PGI2 to purified bone-marrow murine ILC2s has been shown to inhibit IL-33-induced production of IL-5 and IL-13 in WT but not in PGI2-receptor deficient murine ILC2 cultures. 69 Similar findings were reported in purified peripheral human ILC2s cultures. 69 In a mouse model of Alternaria alternata-driven severe asthma, PGI2-receptor deficiency augmented whereas administration of PGI2 analog suppressed IL-5 and IL-13 production by lung ILC2s, airway eosinophilia and mucus production score in the airways. 69 The findings of this study, however, were conflicted by a more recent study in which they showed that in the absence of PGI2-receptor, IFN-γ producing pulmonary NK cells were expanded, house dust mite-induced airway eosinophilia and airway mucus production were reduced. 70 It remains to be addressed whether the seeming discrepancy between the two studies are caused by the type of allergen and allergen exposure protocol.
| Regulation of ILC2s by regulatory T cells
It has been shown that human peripheral blood ILC2s express receptor for Lipoxin A4 and that Lipoxin A4 suppresses IL-13 production by human peripheral ILC2s ex vivo stimulated with PGD2. 71 Further studies are required to identify the mechanisms of the effects of Lipoxin A4 on ILC2s.
| Intrinsic factors in ILC2 regulation
Arginase 1 (Arg1) is an enzyme that plays an important role in cellular metabolism of L-Arginine. Arg1 has been shown to be expressed by fetal liver and adult murine ILC2s. 72, 73 Recent evidence suggests that human lung ILC2s express Arg1 and that this enzyme is crucial for the optimal proliferation of ILC2s during chronic and acute lung inflammation in mice. 74 Arg1 inhibition was found to disrupt amino acid metabolism in ILC2s. 74 These findings suggest that Arg1 is one of the intrinsic regulators of ILC2s. Further studies are required to identify other potentially critical intrinsic factors that regulate ILC2s activation and proliferation.
| Effects of smoking on ILC2s
Cigarette smoke has been associated with lung inflammatory conditions such as asthma and chronic obstructive pulmonary disorder (COPD). 75, 76 Evidence suggests that cigarette smoke augments pathogen-induced COPD exacerbations by deviating the type-2 towards type-1 immune response. 77 It has been shown that cigarette smoke exposure reduces the expression of the IL-33 receptor (ST2) by ILC2 whereas it increased the expression of ST2 by pulmonary macrophages and NK cells in a murine model. 77 Cigarette smoke also increased the expression of IL-33 in the lungs. 77 That study did not show which of the many components in the cigarette smoke mediates the observed results. Recently, we showed that murine and human ILC2s express α7-nicotinic acetylcholine receptor and that a nicotine agonist inhibits ILC2s cytokine production. 78 We showed that nicotine agonist decreases the amount of Gata-3
and dampens the activation of NF-kB pathway. We found a nicotine agonist that alleviates the airway hyperreactivity and inflammation in human ILC2-derived murine model. 78 
| The effects of gut flora and micronutrients on ILC2s
Transcriptional and epigenetic analysis of innate lymphoid cells has shown that depletion of gut flora with antibiotics or the absence of gut flora in germ-free mice is associated with upregulation of ILC3-associated genes such as Atf5, Gpx1, and Cxcl9 in gut ILC2s. 22 It remains to be studied whether these ILC3-associated genes are actually elevated at the protein level in ILC2s upon loss of gut flora.
Moreover, the functional significance of increased expression of such genes in the activation, homeostasis and plasticity of ILC2s is unknown to date.
Micronutrients including vitamins have an impact on the regulation of the immune system and lymphocytes. 79 Deficiency of vitamin A is one of the common deficiencies that lead to defects in immune system. Evidence suggests that deficiency in vitamin A leads to the diminished ILC3s number but increased number of IL-13 producing ILC2s in the intestines of mice and causes resistance to nematode infections. 80 It has been shown that retinoic acid, a vitamin A metabolite, regulates gut-homing receptor expression by ILC1s and ILC3s but not ILC2s in mice. 81 Deficiencies in vitamin A impaired the expression of guthoming receptor only in ILC1 and ILC3s and as a result the number of these cells was diminished in vitamin A deficiency. 81 Whether vitamin
A deficiency has such dramatic effects on human innate lymphoid cells is unknown.
| MEMORY-LIKE PHENOTYPE IN ILC2S
Remembering the previously encountered pathogens and eliciting a more potent response in the subsequent encounters is the definition of immunological memory which is mediated by long-lived T and B memory lymphocytes. Immunological memory is usually associated with antigen specificity and therefore, innate immunological memory is out of the scope of the definition of immunological memory. However, recent evidence suggests that ILC2s may acquire memory-like phenotype. 82 Using a papain or IL-33 to activate pulmonary ILC2s, it was shown that upon stimulation, the number of ILC2s in the lungs or draining lymph nodes increases dramatically and gradually decline but even after a period more than 125 days they do not decline to the pre-stimulation number. 82 Four weeks after stimulation, ILC2s in IL-33 challenged mice found to be more responsive to re-stimulation with IL-33, expanded in higher number and produced more cytokine than those in naive mice. 82 As expected, memory-like ILC2s found to dramatically respond to other allergens than originally exposed but poise the adaptive immunity to the new allergen more efficiently. 82 Further studies may be needed to further identify the phenotype and significance of these cells in worm expulsion and pathogenesis of allergic diseases.
| TRANSCRIPTIONAL REGULATION AND ONTOGENY
ILC2s are significant components of the immune system and their developmental process has received considerable attention from the scientists in the field. Ontogeny of innate lymphoid cells has been described in more details in mice than in humans. 
Gata3, Bcl11b, Rorα, ETS1, Gfi1 and G9a. Transcription factor Gata-3 is a master regulator for Th2 cell differentiation and has been shown to be also critically required for development, maintenance, and function of human and murine ILC2s. 5, 21, [103] [104] [105] [106] Although initially Gata-3 was identified as a transcriptional regulator for ILC2s, soon it was discovered that Gata-3 is required for other innate lymphoid cells as well.
Later, it was found that Gata-3 drives development of ILC3s. 12 Further studies showed that although ILC2s express high levels of Gata-3
for their homeostasis and function, lower level of Gata-3 is required for the development of all IL-7-dependent innate lymphoid cells. 107 Recently it was shown that innate lymphoid cell progenitors express Gata-3 as early as αLP stage maintained high throughout differentiation to ILC2p. 16 Growth factor independence 1 (Gfi1) is a transcription factor that is involved in multilineage hematopoiesis and has been implicated in many pathological conditions including allergic diseases. 108 Gfi1 is required for development and sustained phenotype of ILC2s by driving the expression of Gata-3 and ST2. 109 Loss of Gfi1 in activated ILC2s causes impaired expression of Gata-3 and co-production of IL17A and IL-13 by ILC2s. 109 A more recent evidence suggests that Gfi1 represses Sox4 which drives the expression of RORγt. 110 That finding explains the production of IL-17A by ILC2s in the absence of Gfi1.
Evidence suggests that B-cell lymphoma/leukemia 11B (Bcl11b) is expressed in mature ILC2s and plays a major role for their development. [110] [111] [112] The expression of Bcl11b has been also found in ILC2
progenitors at the stages as early as CHILP. One the most important transcription factors for ILC2 development is RORα. 113 RORα deficient mice do not have ILC2s in any of their organs and fail to mount an ILC2-mediate inflammation. 113, 114 Evidence indicate that Rorα is upregulated at early progenitor stages such as CHILP suggesting that the commitment to ILC2 subset occurs at early stages of development. 16, 101 Recent evidence suggests that transcription factor ETS1 is expressed by mature ILC2s as well as ILC2 precursors including CHILP. 115 In the absence of ETS1, the number of CHILP and ILC2s were decreased possibly due to instability of Id2 expression. 115 In addition to developmental requirement, ETS1 was found to be necessary for the optimal cytokine production by mature ILC2s.
115
Euchromatic histone-lysine N-methyltransferase 2 (EHMT2 or G9a) is an epigenetic modulator that was found to be important in the development of ILC2s by repressing ILC3-associated genes. 116 Mice lacking G9a in hematopoietic cells showed decreased number of ILC2s in the peripheral organs and bone marrow. 116 Repressing ILC3-associated genes through G9a-dependent dimethylation of histone 3 lysine 9 (H3K9me2) was found to underlie the requirement for G9a in ILC2 development. 116 Further studies may be needed to identify the developmental stage in which G9a plays a crucial role.
Despite the notion that priming towards subsets of innate lymphoid cells may occur at the final stages of development of these cells, recent evidence suggests that this priming may happen at the stages as early as CHILP. 16, 90, 101 There is evidence suggesting that CHILP cells are heterogeneous and genes associated with ILC2s such as RORα, Bcl11b and ICOS are upregulated at those early stages of development. 16, 90, 101 The mechanisms that drive such an early stage priming remain to be identified.
| ROLE OF ILC2S IN DISEASE PATHOGENESIS
| Asthma
Asthma is a heterogeneous inflammatory disease of the airways characterized by reversible bronchoconstriction and airway hyperreactivity (AHR) in response to specific and unspecific stimuli. augmented these effects causing a robust lung pathology and mucus hyperplasia. 121 Clinically relevant allergens such house dust mite (HDM), Alternaria alternata, and some respiratory viruses have been shown to activate pulmonary ILC2s and cause lung pathology and asthma-like symptoms in mice. 48, 121, [123] [124] [125] [126] [127] The effects of these allergens in activating ILC2s seem to be indirect and through activation of lung epithelial and antigen presenting cells which in turn produce IL-33, IL-25 and TSLP. 128 It remains to be investigated whether allergens can directly activate ILC2s. One of the mechanisms by which allergens activate epithelial cells is the protease activity and papain, a plant-derived cysteine protease, mimics this effect of allergens in vivo. 129 In addition to protease activity, chitin a polysaccharide in the structure of fungi, arthropods and helminths offers another mechanism for activation of type 2 immune response by allergens and parasites and induction of lung eosinophilic inflammation. 3, 130 135 Further studies indicate that mechanistically IL-13 production from ILC2s promotes activation and migration of pulmonary DCs to the lymph nodes where they facilitate the differentiation of Th2 cells. been shown to attenuate these effects. 124 In addition to allergens, ambient air pollutants such as ozone can also cause asthma. ILC2s have been shown to mediate ozone-induce AHR and airway inflammation. 145, 146 In this allergen-independent asthma, both eosinophils and neutrophils are increased in the lungs and there is evidence that both ILC2s and γδ T cells are involved. 145, 146 Interestingly, there has been a strain difference in ozone sensitivity with BALC/c being more sensitive than B6. 145 Figure 2 summarizes the functional roles of ILC2s in immunity and disease pathogenesis.
| Effects of respiratory viruses on ILC2s
Different respiratory viruses activate pulmonary ILC2s through different pathways. RSV activates ILC2s through induction of TSLP in the lungs causing AHR and mucus production. RSV induces TSLP in the lungs within 12 h post infection and cause increased amounts of IL-13 production and ILC2-number in the lungs as early as 4 days post infection. 133 Neutralizing TSLP using antibody reversed the RSV-induced IL-13 in the lungs and genetic ablation of TSLP inhibits RSV-induced AHR, mucus and IL-13 production in the lungs.
Two lines of evidence suggest that experimental infection with influenza A virus (IAV) in mice causes IL-33 production in the lungs and activation of ILC2s. 123, 147 The first study shows that infection with a H3N1 strain of IAV causes increased number of ILC2s in the lungs, AHR, airway neutrophilia but not eosinophilia by day five post infection. 123 The second study, however, shows a clear production of IL-5
by ILC2s and increased number of eosinophils in the lungs at day 8 after infection with a H1N1 strain of IAV. 147 The seeming discrepancy between the findings of these studies can be due to the difference in the time of analyses after infection or may suggest that different strains of IAV may activate ILC2s through distinct pathways.
Evidence suggests that respiratory viral infections can enhance the subsequent response to allergens. Exposure of mice to pneumonia virus of mice (PVM) 3 days prior to Cockroach (CR) extract has led to higher level of eosinophilic inflammation and mucus production in the lungs than PVM or CR extract alone which was associated with higher viral load and lower weight gain. 
| Evidence of involvement of ILC2s in respiratory allergies in Humans
Several lines of evidence suggest that ILC2s are associated with allergic respiratory inflammation and asthma in humans. One study found that the percentage of ILC2s in the peripheral blood mononuclear cells (PBMCs) was higher in patients with HDM-allergic rhinitis than in patients with mugwort allergic rhinitis. 149 Ex vivo stimulation of PBMCs with IL-33, IL-25 and IL-2 induced significantly higher amount of IL-5 and IL-13 in patients with HDM-allergic rhinitis. 149 Another study found that the frequency and absolute number of ILC2s are increased in the PBMC of allergic asthmatics compare to allergic rhinitis or healthy controls. 35 Total PBMCs of allergic asthmatic patients produced higher amount of IL-5 and IL-13 in response to IL-25 or IL-33 than those of allergic rhinitis or healthy controls. 35 A different F I G U R E 2 Activation, regulation and the role of ILC2s in health and disease. ILC2s can be activated by several stimuli including cytokines, IL-33, TSLP, IL-25, eicosanoids, PGD2 and leukotrienes. ILC2s play important roles in the pathogenesis of asthma and atopic dermatitis by producing IL-5 and IL-13. Beneficial effects of ILC2s include contribution to repair mucosal tissue damage due to worm migration or viral infections through IL-13 and repair associated genes. ILC2s play an important role in worm expulsion through production of IL-5 and IL-13. ILC2s contribute to controlling obesity by converting the white to beige adipocytes. ILC2s can be suppressed by nicotine, interferons, Lipoxin A, and PGI2 and regulatory T cells through ICOS/ICOS-L interaction and TGF-β study found that the total number of ILC2s in the blood and sputum of patients with severe asthma was higher than in patients with mild asthma. 150 This study showed that the number of IL-5 + IL-13 + ILC2s was higher in the sputum of patients with severe asthma than patients with mild asthma. 150 The number of ILC2s in the biopsies of sinus mucosa was found to be higher in patients with chronic rhinosinusitis and nasal polyps who concurrently had asthma. 151, 152 Higher number of ILC2s has been observed in the induced sputum of children with severe therapy resistant asthma compared to children with control children who didn't have asthma.
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A study on the effects of rhinovirus infection in asthmatic patients found evidence for the activation of ILC2s by rhinovirus infection. 154 That study showed that in vitro infection of human primary lung epi- Allergen-specific IgE are produced in allergic asthmatic patients.
A recent study provides evidence that ILC2s can contribute to the production of IgE by B cells. 155 That study showed that upon stimulation with IL-25 or IL-33, human peripheral ILC2s can enhance IgE production from autologous B cells through expression of CD154 and IL-4 production in vitro. 155 The functional significance of ILC2s for IgE production by B cells in allergic and asthmatic patients is unknown.
| ILC2s in pulmonary fibrosis
Idiopathic pulmonary fibrosis is a serious chronic fibrosing interstitial pneumonia due to unknown causes. 156 Experimental evidence suggests that ILC2s play a role in the pathogenesis of pulmonary fibrosis by producing IL-13. 157, 158 Bleomycin-induced pulmonary fibrosis in mice was found to be associated with increased pulmonary amounts of IL-25 in one study and IL-33 in another study. 157, 158 The first study found that IL-25 receptor and the second showed that IL-33 receptor deficiencies were associated with reduced bleomycin-induced fibrosis in the lungs of mice. 157, 158 Both studies showed that activation of ILC2s and their IL-13 production play a major role in the observed pathology.
| Atopic dermatitis
The first evidence for contribution of ILC2s to the pathogenesis of atopic dermatitis (AD) in human comes from a study that showed ILC2s reside in the human skin and their number is increased in AD patients compare to healthy individuals. 20 This study showed that
ILC2s are recruited to the skin of HDM-sensitized patients upon skin allergen challenge and that skin ILC2s produce large quantities of IL-5 and IL-13 in response to ex vivo stimulation with IL-33. 20 In mice, dermal ILC2s were identified and it was shown that that skin specific expression of IL-33 activates skin ILC2s and causes AD-like pathology in the skin of mice. 159, 160 Loss of filaggrin is a cardinal feature in AD. Interestingly, it has been shown that filaggrin mutant mice spontaneously develop AD which was mediated by IL-5 producing ILC2s in the skin and independent of adaptive immunity. 161 The effects of tolerance on ILC2s are mainly unknown; however, a recent study showed that oral tolerance inhibited the type-2 inflammation including ILC2s in an ovalbumin-driven-AD model in mice. In contrast, beige adipocytes dissipate energy for thermogenesis and maintaining body temperature. 171 Conversion of white adipose tissue (WAT) to beige adipose tissue (BAT) is considered beneficial to limit obesity. The low-grade chronic inflammation associated with obesity is an underling mechanism for development of diabetes and cardiovascular diseases. It has been shown that IL-25 activated ILC2s increase the number of eosinophils and alternatively activated macrophages in the adipose tissue and lead to weight loss and improve glucose tolerance in obese mice. 169 Subsequent studies showed that activation of ILC2s can promote the conversion of WAT to BAT in the so-called 'process of browning'. 172, 173 These studies showed that ILC2s promote generation of beige adipocytes independent of adaptive immunity. However, one study showed a role for eosinophils and IL-4 receptor for stimulating the proliferation of bipotential adipocyte precursor to potentiate the generation of beige adipocytes. 173 The other study found that ILC2s produce methionine-enkephalin peptides that directly induces the beige adipocyte-associated uncoupling protein 1 independent of IL-4 or eosinophils. 172 The findings of these studies may suggest multiple pathways by which ILC2s can contribute to browning of the WAT and limiting obesity.
There is an interesting interplay between asthma and obesity.
Asthma can lead to obesity and obesity can cause asthma through incompletely understood mechanisms. Although, obesity-associated asthma is distinct from allergic asthma, evidence suggests that obesity plays an important role in asthma exacerbations. 174, 175 A recent study using diet-induced obesity has shown that obesity leads to increased production of IL-5 by ILC2s that caused elevated number of eosinophils in the lungs. 176 This study showed that intranasal HDM exposure causes a higher level of AHR and airway eosinophilic inflammation in obese than lean mice. 176 
| Tissue repair
Different lines of evidence from murine studies suggest that ILC2s are involved in the process of tissue repair. In murine models of infection with helminth, N. brasiliensis, ILC2s were found to alleviate the lung tissue damage during the pulmonary transition stages of the worm. 31, 32 Mechanistically, production of IL-13 by ILC2s was associated with expression of genes such as Muc5a, Clca3, and Tff2, in lung epithelial cells, however, none of the suggested genes were functionally examined. 31 ILC2s were found to play a role in cutaneous wound healing in a mouse model of splinted excisional wound. 177 Depletion of ILC2s in an influenza experimental infection was found to aggravate the loss of epithelial integrity cause by IAV in mice. 178 This study found that ILC2s were enriched in genes associated with wound healing and identified Amphiregulin as a mechanism underlying ILC2-mediated regaining epithelial integrity. 178 Same group has also shown that ILC2s play a protective role in dextran sulfate sodium (DSS)-induced colitis and alleviate its intestinal pathology in mice through Amphiregulin. 179 
| PLASTICITY OF ILC2S
As mentioned earlier, innate lymphoid cells are terminally differentiated cells and their cytokine and transcription factor signature identifies the three subsets of ILC1, ILC2, and ILC3 resembling the The first line of evidence showed a partial loss of CRTH2 in in vitro expanded human peripheral ILC2s 4 days after adoptive transfer to NSG mice, which lack B and T cells and innate lymphoid cells. 18 It was further shown that human ILC2s downregulated CRTH2 in response to IFN-γ. 18 This study found that activation of human ILC2s by IL-1β primes these cells to respond to type 1 cytokine IL-12 by downregulating CRTH2 and producing IFN-γ. 18 ILC2 responsiveness to IL-12 was inhibited by IL-4 and it was suggested that eosinophil-derived IL-4 enforces ILC2 phenotype in a cross-talk between ILC2s and eosinophils. 18 A different study found a role for basophil-derived IL-4 in controlling the function of ILC2s in murine model of lung inflammation. 36 The second line of evidence found that a proportion of human purified ILC2s co-produce IFN-γ with IL-13 in vitro only when cultured in the presence of stromal cells. 180 They found that plastic clones of human ILC2s co-express ILC1 transcription factor T-bet. 180 It was observed that ILC2s from IL-12Rβ1-deficient donors do no show plasticity in vitro and it was concluded that the plasticity of ILC2s towards ILC1-like cells was mediated by IL-12. 180 A different study provides similar evidence for plasticity of human and murine ILC2s towards
ILC1s
. 181 This study also showed that influenza infection causes loss of Gata-3 and gain of T-bet by murine ILC2s, and production of IFN-γ by these cells which contributed to antiviral immunity. 181 Although these findings provide interesting bases for understanding plasticity of ILC2s, they are in clear contrast with prior findings that influenza infection causes activation of murine ILC2s and induces IL-5 and IL-13 production by these cells. 123, 147, 178 Further studies are required to identify the mechanisms of regulation of ILC2s under infectious and inflammatory conditions. Deficiency in Bcl11b has been shown to developmentally cause ILC3-like phenotype in ILC2s. [110] [111] [112] A recent study suggests that Notch signaling causes a ILC3-like phenotype in a subset of ILC2s and promotes co-production of IL-17 with IL-13 in these cells. 182 Although these findings seem to be interesting, the study heavily relies on the expression level of KLRG-1 for defining ILC2s. 182 Without evaluating the expression level of IL-33R, IL-2Rα or IL-25R it is unclear whether the described cells can be categorized as true ILC2s. 
| CONCLUSIONS/CONCLUDING REMARKS
